Pharma Marketing Talk
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Curation vs. Content Marketing
Which is Best for Pharma Marketers?

Pharmaguy interviews Arsalan Arif (see Bio), Publisher of ENDPOINTS, about the benefits versus the drawbacks of content curation versus content marketing for pharmaceutical marketers in a social media world.

Recorded on Thursday, 25 February 2016

Check Out More Podcasts by Pharmaguy on BlogTalkRadio

You can also visit this Pharma Marketing Talk Segment Page to listen to the archived audio podcast. This show and ALL Pharma Marketing Talk shows are available as podcasts via PMT on iTunes (FREE!). We discuss the value of curated pharma/health content. Specifically: Can pharma marketers do content curation? Or are they too focused on "content marketing?"

Guest Bio

Arsalan Arif Arsalan Arif is the founder and publisher of ENDPOINTS, a daily digest of essential biotech news.

Previously, Arsalan led FierceBiotech and the Life Sciences Group to become the most widely read biopharmaceutical news source in the world.

Arsalan is also a media engineer with a record creating profitable, high-profile daily news products. His focus is on business news journalism, brand building, digital advertising sales, and talent evaluation.

Links to More Information

5-Minute Pharmaguy

Listen to internet radio with Pharmaguy on Blog Talk Radio

Contact Information
Pharma Marketing Network

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.